Matches in Wikidata for { <http://www.wikidata.org/entity/Q94586880> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q94586880 description "article scientifique publié en 2020" @default.
- Q94586880 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94586880 description "scientific article published on 17 April 2020" @default.
- Q94586880 description "wetenschappelijk artikel" @default.
- Q94586880 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q94586880 name "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 name "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 type Item @default.
- Q94586880 label "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 label "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 prefLabel "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 prefLabel "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 P1433 Q94586880-B93700BE-2C02-4206-B3A0-6686B5271467 @default.
- Q94586880 P1476 Q94586880-DBE41921-9418-4C39-8B1A-D83D6B010C12 @default.
- Q94586880 P2093 Q94586880-16548E2F-5093-49F1-8970-05A369E4894F @default.
- Q94586880 P2093 Q94586880-44DBFC40-7E0C-435A-9D2B-4A9DD8194F6E @default.
- Q94586880 P2093 Q94586880-7F1A9557-5274-4102-9F6E-87C9C33F69E4 @default.
- Q94586880 P2093 Q94586880-BF8CF896-3B5D-409C-B425-24405D1FBAAE @default.
- Q94586880 P2093 Q94586880-E4EACCE8-275D-4682-8BBB-2631A37D4BB4 @default.
- Q94586880 P2093 Q94586880-F3D87C3D-5960-47D7-91D3-163BDA069D48 @default.
- Q94586880 P31 Q94586880-DE3F224A-9204-41D6-8773-202427DDB08D @default.
- Q94586880 P356 Q94586880-FC1D861D-26FA-48C9-91FE-66223A6C26B3 @default.
- Q94586880 P577 Q94586880-51A2993D-C6CB-46E2-9F9C-8BB84EE770A6 @default.
- Q94586880 P698 Q94586880-59A20A5D-945E-40C5-9A8B-4FAD41F1216E @default.
- Q94586880 P921 Q94586880-67BDBE72-0822-4593-B52B-625894BA2E34 @default.
- Q94586880 P921 Q94586880-C21439CF-E0AE-4DBC-88A7-4EE9A3F87705 @default.
- Q94586880 P356 J.AMJMS.2020.04.006 @default.
- Q94586880 P698 32376001 @default.
- Q94586880 P1433 Q7713509 @default.
- Q94586880 P1476 "Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia" @default.
- Q94586880 P2093 "Amie Algrim" @default.
- Q94586880 P2093 "Carolyn Cummings" @default.
- Q94586880 P2093 "Christopher K Finch" @default.
- Q94586880 P2093 "Ethan H Adams" @default.
- Q94586880 P2093 "Jennifer D Twilla" @default.
- Q94586880 P2093 "Michael Samarin" @default.
- Q94586880 P31 Q13442814 @default.
- Q94586880 P356 "10.1016/J.AMJMS.2020.04.006" @default.
- Q94586880 P577 "2020-04-17T00:00:00Z" @default.
- Q94586880 P698 "32376001" @default.
- Q94586880 P921 Q188121 @default.
- Q94586880 P921 Q415739 @default.